Trimeris, Inc. receives Audit Committee Deficiency notification From Nasdaq. The company is informed not to be in compliance with the Nasdaq audit committee requirement for continued listing as set forth in Marketplace Rule 4350 due to the resignation on 15 December 2008 of Director Kevin C. Tang.
At the time of his resignation, Tang served on the Company’s audit committee. His resignation was previously announced by the Company on a Form 8-K filed with the Securities and Exchange Commission on 16 December 2008.
Consistent with Marketplace Rule 4350(d)(4), Nasdaq will provide the Company with a cure period to regain compliance. The cure period runs until the earlier of 15 December 2009 or Trimeris’ next annual meeting of stockholders. If company’s annual meeting of stockholders is held before 15 June 2009, then compliance with the listing standard must be achieved no later than 15 June 2009.
L.D.